arrow
R

Richard Newcomb

mass general brig ham cancer institute
H指数:16
被引数:996

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reduced-Dose Post-Transplant Cyclophosphamide (PTCy 40-40) in Allogeneic Hematopoietic Cell Transplantation

异基因造血细胞移植中低剂量移植后环磷酰胺的应用(PTCy 40-40)

2026-08-230
PRE
Safe and effective addition of ruxolitinib to graft-versus-host prophylaxis in older adults undergoing reduced-intensity allogeneic hematopoietic cell transplantation

在老年患者接受减低强度异基因造血细胞移植时,将ruxolitinib安全有效地添加到移植物抗宿主病预防方案中。

2025-08-110
PRE
A multimodal sexual dysfunction intervention versus enhanced usual care for survivors of haematopoietic stem-cell transplantation: a single-centre, open-label, randomised clinical trial

一种多模式性功能障碍干预与增强常规护理的比较:针对造血干细胞移植幸存者的单中心、开放标签、随机临床试验

2025-08-040
PRE
Prolonged Hospitalization for Hematopoietic Cell Transplantation: Characteristics, Risk Factors and Associations with Patient-Reported and Clinical Outcomes

造血细胞移植的长期住院:特征、风险因素及其与患者报告结局和临床结局的关联

2025-06-100
PRE
Corrigendum to Quality of Life and Prognostic Awareness in Caregivers of Patients Receiving Chimeric Antigen Receptor T-Cell Therapy Transplantation and Cellular Therapy, 30 (2024) 452 - 453

勘误:生活质量与预后认知在接收嵌合抗原受体T细胞疗法患者照护者中的研究,《移植与细胞疗法》,30(2024)452-453

2025-04-030
PRE
Long-Term Cognitive Outcomes in Adult Patients Receiving Chimeric Antigen Receptor T-Cell Therapies

接受嵌合抗原受体T细胞疗法的成年患者的长期认知结果

2025-01-010
PRE
Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients

黑人和白人患者急性移植物抗宿主病 (GVHD) 严重程度及其结局的差异

2024-11-011
PRE
Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract

第三方粪便微生物移植用于高风险治疗-下消化道的急性GVHD

2024-04-264
OAAI